Skip to content

MARVIL MEDIC

Active Private limited companyfounded 2010active for 16 yearsRue des Abreuvoirs, Spy 1A, 5190 Jemeppe-sur-SambreKBO/BCE: BE 0824.366.673 #7 company by equity in Jemeppe-sur-Sambre, Health and social work sector

Lifetime

16 annual accounts with figures on one time axis
peak of €121,942 in 2024
€119,734▼ 1.8%
lowest -€2,561 in 2010
€87,821▼ 7.8%
peak of €438,976 in 2025
€438,976▲ 25.0%
€35,965▲ 66.8%
Board2 names since 2010
2 directors and 1 other
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Equity from €351,155 to €438,976Debts from €21,566 to €35,965Cash from €83,319 to €183,906

Key points

from the 2025 annual accounts

Equity

€438,976 ▲ 25.0%

MARVIL MEDIC has made a profit without a break since 2011.

Filings

16 annual accounts since 2010
AprilJune31 JulyOctober2010201520202025

Ten of the last ten came late. The 2024 accounts came in latest, 141 days after the end of the period.

Position in the sector

92.4%

Higher solvency than 87% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as MARVIL MEDIC has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for MARVIL MEDIC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 22-12-2023
Manager
  • 186 sharesdeed of 30-03-2010
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0824366673
changes role from manager to director Discharge granted to · Gazette deed
Registered office moved from Moustier-Sur-Sambre to Spy The registered office moved from Rue de la Glacerie 101 à 5190 MOUSTIER-SUR-SAMBRE to Rue des Abreuvoírs 1a à 5190 SPY · General meeting of 03-12-2014 · Gazette deed
is in office as manager Gazette deed
All 31 events

Comparable companies

same main activity, similar in size and age
Company
MARVIL MEDIC Jemeppe-sur-Sambre €474,941 €119,734 92.4% -
Docteur Cécile Taormina Fosses-la-Ville €420,188 €123,504 84.8% -
Docteur Isabelle Tancré Namur €425,501 €115,183 93.1% -
Cabinet Medical du Docteur Anita Chanteux Herve €490,744 €121,335 80.1% -
Dr. Sabine Reeckmans Heusden-Zolder €479,147 €123,987 89.2% -
MEDISCH KABINET Dr DECLEYRE PETER Meise €499,821 €121,811 43.1% -
MEDISCH KABINET DR DU RANG ANNICK Ternat €472,745 €115,219 83.9% -

These companies have the same main activity as MARVIL MEDIC: general medical practice (NACE 86210). They are comparable in size and age: total assets between €420,000 and €500,000, founded between 2007 and 2010.

Official details

Source: KBO
Status
Active since 26-03-2010Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.188.009.6975190 Jemeppe-sur-Sambre, registered on 26-03-2010
Financial year end
31 December
Peppol
Reachable since 08-12-2025
Company details

Annual accounts 2025

≈ €220,000estimated
€474,941▲ 27.4%
Filing
Filed on 31-08-2026
Financials

Insights on MARVIL MEDIC

MARVIL MEDIC files the micro format. That format states no turnover. The gross margin rose from €27,058 in 2010 to €119,734 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MARVIL MEDIC

What is the company number of MARVIL MEDIC?
The company number of MARVIL MEDIC is 0824.366.673. The VAT number is the same number with BE in front: BE 0824.366.673.
Where is MARVIL MEDIC based?
The registered office is at Rue des Abreuvoirs, Spy 1A, 5190 Jemeppe-sur-Sambre.Company details
What does MARVIL MEDIC do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of MARVIL MEDIC?
MARVIL MEDIC is a private limited company (BV).
When was MARVIL MEDIC founded?
MARVIL MEDIC was founded on 26-03-2010.
Is MARVIL MEDIC still active?
Yes, MARVIL MEDIC is an active enterprise in the KBO register.
What is the turnover of MARVIL MEDIC?
The turnover in financial year 2025 is about €220,000. This figure is estimated from the gross margin of €119,734 and 30 comparable companies (NACE 86210). It probably lies between €170,000 and €270,000.Financials
Is MARVIL MEDIC profitable?
In financial year 2025, MARVIL MEDIC made a profit of €87,821.
Where can I find the annual accounts of MARVIL MEDIC?
MARVIL MEDIC filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MARVIL MEDIC due?
MARVIL MEDIC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.